NASDAQ:MATK
$31.49   - 0.01 		Feb 25, 2011
4:00 PM ET

Martek Biosciences Corporation

Celebrating 15 years with NASDAQ

Home • Investors • Investor FAQs

Investor FAQs

show all
Martek is now a wholly owned subsidiary of DSM.